Immunophenotyping of Rhesus CMV‐Specific CD8 T‐Cell Populations

A vaccine to ameliorate cytomegalovirus (CMV)‐related pathogenicity in transplantation patients is considered a top priority. A therapeutic vaccine must include components that elicit both neutralizing antibodies, and highly effective CD8 T‐cell responses. The most important translational model of v...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cytometry A
Autori principali: Pomplun, Nicholas L., Vosler, Logan, Weisgrau, Kim L., Furlott, Jessica, Weiler, Andrea M., Abdelaal, Hadia M., Evans, David T., Watkins, David I., Matano, Tetsuro, Skinner, Pamela J., Friedrich, Thomas C., Rakasz, Eva G.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2020
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7855655/
https://ncbi.nlm.nih.gov/pubmed/32713108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cyto.a.24197
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi